Robert E. Reiter
Corporate Officer/Principal en Jonsson Comprehensive Cancer Center .
Perfil
Robert E.
Reiter is the founder of ImaginAb, Inc. which was founded in 2007.
He is currently the Director-Genitourinary Cancer Program at Jonsson Comprehensive Cancer Center and a Professor-Urology & Molecular Biology at David Geffen School of Medicine.
Dr. Reiter received his undergraduate degree from Yale University and his doctorate from Stanford University School of Medicine.
Cargos activos de Robert E. Reiter
| Empresas | Cargo | Inicio |
|---|---|---|
| Jonsson Comprehensive Cancer Center | Corporate Officer/Principal | - |
| David Geffen School of Medicine | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Robert E. Reiter.
| Empresas | Cargo | Fin |
|---|---|---|
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Fundador | - |
Formación de Robert E. Reiter.
| Yale University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
| Jonsson Comprehensive Cancer Center |
- Bolsa de valores
- Insiders
- Robert E. Reiter